elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53484390-CE8B63A7-F30D-460C-903A-9EC2675073F4
Q53484390-CE8B63A7-F30D-460C-903A-9EC2675073F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53484390-CE8B63A7-F30D-460C-903A-9EC2675073F4
Imatinib treatment of therapy resistant generalized deep morphea.
P2860
Q53484390-CE8B63A7-F30D-460C-903A-9EC2675073F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53484390-CE8B63A7-F30D-460C-903A-9EC2675073F4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ad06425721c90a575a1a895a46fc797493d79fa1
P2860
Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.